# US 2015/0104420 A1 · Dairy administered bacterial composition

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0104420 A1
- Document ID: US20150104420A1
- Status: Published application
- Kind: A1
- Application number: 14/575,974
- Filed: 2014-12-18
- Published: 2015-04-16
- Earliest claimed: 2014-12-18
- Assignees: Microbios, Inc.
- Applicants: MicroBios, Inc.
- Inventors: Joseph F. Flint; Matthew Ryan Garner
- Web page: https://patentgrep.com/patent/US20150104420A1

## CPC

- A61K 35/747: Lactobacilli, e.g. L. acidophilus or L. brevis
- A61K 35/742: Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
- A61K 35/744: Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- Y02A 50/30: Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

A dairy administered animal feed additive that promotes animal health and growth, reduces scours and mortality, and can act as an antibiotic substitute. The additive inhibits pathogen growth resulting in lower pathogen load within the animal and reduced pathogen sheading to the environment. The additive includes bacteria that inhibits E. coli O157:H7 growth by as much as 93% and Salmonella growth by as much as 97%, together with commensurate inhibition rates against the Big-Six Escherichia coli strains referred to as the non-O157 STECs that include E. coli O121:H19; E. coli O45:H2; E. coli O103:H11; E. coli O145, E. coli O26:H11; and E. coli O111. The additive is constituted of various combinations of the following four pathogen-inhibiting bacteria: (1) Lactobacillus animalis strain MB101; (2) Lactobacillus animalis strain MB102; (3) Enterococcus faecium strain MB505; and (4) Pediococcus acidilactici strain MB902. The bacteria are deposited with the American Type Culture Collection (ATCC).

## Claims

### Claim 1

A composition for administration to a dairy animal comprising:
at least two bacteria selected from the group consisting of:
Lactobacillus animalis strain MB101 having ATCC Accession Number PTA-121710;
Lactobacillus animalis strain MB102 having ATCC Accession Number PTA-121711;
Enterococcus faecium strain MB505 having ATCC Accession Number PTA-121709; and
Pediococcus acidilactici strain MB902 having ATCC Accession Number PTA-121712; and
a carrier suitable for consumption by a dairy animal.

### Claim 2 (depends on 1)

The composition recited in claim 1 comprising:
Lactobacillus animalis strain MB101 having ATCC Accession Number PTA-121710; and
Lactobacillus animalis strain MB102 having ATCC Accession Number PTA-121711.

### Claim 3 (depends on 1)

The composition recited in claim 1 comprising:
Lactobacillus animalis strain MB101 having ATCC Accession Number PTA-121710;
Lactobacillus animalis strain MB102 having ATCC Accession Number PTA-121711; and
Enterococcus faecium strain MB505 having ATCC Accession Number PTA-121709.

### Claim 4 (depends on 1)

The composition recited in claim 1 comprising:
Lactobacillus animalis strain MB101 having ATCC Accession Number PTA-121710;
Lactobacillus animalis strain MB102 having ATCC Accession Number PTA-121711;
Enterococcus faecium strain MB505 having ATCC Accession Number PTA-121709; and
Pediococcus acidilactici strain MB902 having ATCC Accession Number PTA-121712.

### Claim 5 (depends on 1)

The composition recited in claim 1 comprising:
Lactobacillus animalis strain MB101 having ATCC Accession Number PTA-121710; and
Enterococcus faecium strain MB505 having ATCC Accession Number PTA-121709.

### Claim 6 (depends on 1)

The composition recited in claim 1 comprising:
Lactobacillus animalis strain MB101 having ATCC Accession Number PTA-121710;
Enterococcus faecium strain MB505 having ATCC Accession Number PTA-121709; and
Pediococcus acidilactici strain MB902 having ATCC Accession Number PTA-121712.

### Claim 7 (depends on 1)

The composition recited in claim 1 comprising:
Lactobacillus animalis strain MB101 having ATCC Accession Number PTA-121710; and
Pediococcus acidilactici strain MB902 having ATCC Accession Number PTA-121712.

### Claim 8 (depends on 1)

The composition recited in claim 1 comprising:
Lactobacillus animalis strain MB101 having ATCC Accession Number PTA-121710;
Lactobacillus animalis strain MB102 having ATCC Accession Number PTA-121711; and
Pediococcus acidilactici strain MB902 having ATCC Accession Number PTA-121712.

### Claim 9 (depends on 1)

The composition recited in claim 1 comprising:
Lactobacillus animalis strain MB102 having ATCC Accession Number PTA-121711; and
Enterococcus faecium strain MB505 having ATCC Accession Number PTA-121709.

### Claim 10 (depends on 1)

The composition recited in claim 1 comprising:
Lactobacillus animalis strain MB102 having ATCC Accession Number PTA-121711;
Enterococcus faecium strain MB505 having ATCC Accession Number PTA-121709; and
Pediococcus acidilactici strain MB902 having ATCC Accession Number PTA-121712.

### Claim 11 (depends on 1)

The composition recited in claim 1 comprising:
Lactobacillus animalis strain MB102 having ATCC Accession Number PTA-121711; and
Pediococcus acidilactici strain MB902 having ATCC Accession Number PTA-121712.

### Claim 12 (depends on 1)

The composition recited in claim 1 comprising:
Enterococcus faecium strain MB505 having ATCC Accession Number PTA-121709; and
Pediococcus acidilactici strain MB902 having ATCC Accession Number PTA-121712.

### Claim 13 (depends on 1)

The composition recited in claim 1 wherein at least one strain is a pathogen growth inhibitor.

### Claim 14 (depends on 1)

The composition recited in claim 1 wherein at least one strain is an E. coli O157:H7 growth inhibitor.

### Claim 15 (depends on 1)

The composition recited in claim 1 wherein at least one strain is a growth inhibitor to the non-O157 STEC, Big-Six Escherichia coli strains including E. coli O121:H19; E. coli O45:H2;
E. coli O103:H11; E. coli O145, E. coli O26:H11; and E. coli O111.

### Claim 16 (depends on 1)

The composition recited in claim 1 wherein at least one strain is a Salmonella growth inhibitor.

### Claim 17 (depends on 1)

The composition recited in claim 1 wherein at least one strain is a Salmonella typhimurium growth inhibitor.

### Claim 18 (depends on 1)

The composition recited in claim 1 wherein at least one strain is a Salmonella enteriditis growth inhibitor.

### Claim 19 (depends on 1)

The composition recited in claim 1 wherein each strain is a pathogen growth inhibitor.

### Claim 20 (depends on 1)

The composition recited in claim 1 wherein each strain is an E. coli O157:H7 growth inhibitor.

### Claim 21 (depends on 1)

The composition recited in claim 1 wherein each strain is a growth inhibitor to the non-O157 STEC, Big-Six Escherichia coli strains including E. coli O121:H19; E. coli O45:H2; E. coli O103:H11; E. coli O145, E. coli O26:H11; and E. coli O111.

### Claim 22 (depends on 1)

The composition recited in claim 1 wherein each strain is a Salmonella growth inhibitor.

### Claim 23 (depends on 1)

The composition recited in claim 1 wherein each strain is a Salmonella typhimurium growth inhibitor.

### Claim 24 (depends on 1)

The composition recited in claim 1 wherein at least one strain is a Salmonella enteriditis growth inhibitor.

### Claim 25 (depends on 1)

The composition recited in claim 1 wherein the carrier is tailored for consumption by a dairy animal.

### Claim 26 (depends on 1)

The composition recited in claim 1 wherein the composition is sealed in a container marked for dairy animal consumption.

### Claim 27

A composition for administration to a dairy animal comprising:
at least one bacteria selected from the group consisting of:
Lactobacillus animalis strain MB102 having ATCC Accession Number PTA-121711;
Enterococcus faecium strain MB505 having ATCC Accession Number PTA-121709; and
Pediococcus acidilactici strain MB902 having ATCC Accession Number PTA-121712; and
a carrier suitable for consumption by a dairy animal.
